Worldwide Healthcare Trust Plc (LON:WWH)


Worldwide Healthcare Trust PLC, formerly known as previously known as Finsbury Worldwide Pharmaceutical, is a UK based investment trust. Its portfolio consists of biotechnology and healthcare companies across the globe. It was founded in 1995 and is publicly listed on the London Stock Exchange. It is also a part of the FTSE 250 index. The portfolio manager of the Trust since its inception is OrbiMed Capital LLC, which was founded in 1989 and has evolved over time to be the largest dedicated healthcare investment firm in the world. In 2014, the company appointed Frostrow Capital as the Alternative Investment Fund Manager for the Company. This was done to ensure compliance with the Alternative Investment Fund Managers Directive (AIFMD). The company tries to ensure compliance with AIFMD through a synchronized relationship between OrbiMed and Frostrow Capital LLP and itself.  The aim is to reduce portfolio volatility through appropriate risk management.

The goal of the trust is to invest in global healthcare and achieve maximum capital growth. The investments are made in shares of a variety of biotechnology and pharmaceutical companies and other related securities in the healthcare sector, using gearing and derivative transactions, to reduce the risks associated with investment and simultaneously increase the returns. Approximately 60% of the portfolio of the trust is invested in large companies and 20% of the portfolio of the trust in small companies. It covers about 1,000 companies ranging from early-stage companies with pre-clinical assets to full integrated biopharmaceutical companies. At the time of acquisition, over 5% of the investments in the portfolio can also be made in debt instruments, convertibles and royalty bonds issued by biotechnology and pharmaceutical companies. At the same time, 20% of the portfolio can be invested in companies belonging to healthcare sectors like equipment and supplies, technology, and providers of services.

The company follows well defined standards of corporate governance with Anti-bribery and Corruption Policies. It also has a zero-tolerance approach to the criminal facilitation of tax evasion. It has received various awards like Investment Trust of the Year Awards 2019 (for Biotechnology & Healthcare), Investment Trust Awards 2014 (for Best Sector Specialist Investment Trust), Investment Trust of the Year Awards 2010 (for specialist), Standard & Poor’s Micropal 1 Year UK Investment Trust 2002 as well as 2003 (for Biotech & Life Sciences).

Contact Information

company address 25 Southampton Buildings WC2A 1AL United Kingdom

company phone+44.20.30084910

company website

Similar Companies